Sequential neoadjuvant chemoradiotherapy (CRT) followed by curative surgery vs. primary surgery alone for resectable, non-metastasized pancreatic adenocarcinoma: NEOPA- a randomized multicenter phase III study (NCT01900327, DRKS00003893, ISRCTN82191749)

BACKGROUND: Median OS after surgery in curative intent for non-metastasized pancreas cancer ranges under study conditions from 17.9 months to 23.6 months. Tumor recurrence occurs locally, at distant sites (liver, peritoneum, lungs), or both. Observational and autopsy series report local recurrence r...

Descripción completa

Detalles Bibliográficos
Autores principales: Tachezy, Michael, Gebauer, Florian, Petersen, Cordula, Arnold, Dirk, Trepel, Martin, Wegscheider, Karl, Schafhausen, Phillipe, Bockhorn, Maximilian, Izbicki, Jakob Robert, Yekebas, Emre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4057592/
https://www.ncbi.nlm.nih.gov/pubmed/24906700
http://dx.doi.org/10.1186/1471-2407-14-411

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4057592/
https://www.ncbi.nlm.nih.gov/pubmed/24906700
http://dx.doi.org/10.1186/1471-2407-14-411

Ejemplares similares